Lars H. Lindner - Publications

Prognostic Factors and Survival Outcomes in Resectable Thoracic Soft Tissue and Bone Sarcomas.

Journal: Cancers

Published: May 12, 2026

Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study.

Journal: Oncology and therapy

Published: April 21, 2026

Response to Letter to the Editor: Comments on "Surgery for Retroperitoneal Soft Tissue is Safe following Multimodal Treatment with Regional Hyperthermia".

Journal: Annals of surgical oncology

Published: April 20, 2026

Variations in surgical strategies and treatment allocation for retroperitoneal sarcomas across German-speaking sarcoma centres.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 30, 2026

Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome.

Journal: The New England journal of medicine

Published: March 04, 2026

Sarcomas : Clinical introduction

Journal: Radiologie (Heidelberg, Germany)

Published: January 11, 2026

Neoadjuvant chemotherapy for soft-tissue sarcoma of the extremities: A post-hoc Sarculator-based risk analysis of the EORTC 62961-ESHO 95 randomized trial.

Journal: Cancer

Published: November 26, 2025

Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis.

Journal: Journal of cancer research and clinical oncology

Published: November 24, 2025

Correction: Surgery for Retroperitoneal Soft Tissue Sarcoma is Safe Following Multimodal Treatment with Regional Hyperthermia.

Journal: Annals of surgical oncology

Published: November 20, 2025

Stereotactic heart ablative radiotherapy (SHARP): a prospective multicentric phase II trial.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: November 10, 2025

ASO Visual Abstract: Surgery for Retroperitoneal Soft Tissue Sarcoma is Safe Following Multimodal Treatment with Regional Hyperthermia.

Journal: Annals of surgical oncology

Published: October 03, 2025

Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy.

Journal: Scientific reports

Published: September 27, 2025